Position in ARGX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$127,415,291
+$25,632,319 QoQ
Shares Held
137,335
-1.5% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#32
of 505 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. ARGX ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
This page
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,415,291 | 137,335 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $101,782,972 | 139,381 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $113,284,372 | 134,710 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $65,439,270 | 88,724 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,985,812 | 19,930 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $57,360,003 | 96,914 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $62,745,375 | 102,025 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $57,834,513 | 106,690 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $68,637,392 | 159,607 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $62,824,718 | 159,567 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $72,055,342 | 189,405 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $60,086,619 | 154,175 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $160,669,161 | 431,234 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $163,373,844 | 431,259 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $148,548,962 | 420,759 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $131,458,854 | 346,967 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $96,970,436 | 307,540 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,686,164 | 4,815 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,491,500 | 8,250 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,065,185 | 3,538 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,407,949 | 12,375 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,334,486 | 7,938 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,463,810 | 5,576 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,426,239 | 24,092 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $16,466 | 125 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||